Scott Eggener to Antineoplastic Agents, Hormonal
This is a "connection" page, showing publications Scott Eggener has written about Antineoplastic Agents, Hormonal.
Connection Strength
0.268
-
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis. Lancet. 2026 03 14; 407(10533):1059-1071.
Score: 0.219
-
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 08; 22(4):102103.
Score: 0.048